Evidence map›Paper›PMID 31148565›Full record

ArticleScientific reports2019

Periodontal treatment prevents arthritis in mice and methotrexate ameliorates periodontal bone loss.

Paul M Lübcke, Meinolf N B Ebbers, Johann Volzke, Jana Bull, Susanne Kneitz, Robby Engelmann, Hermann Lang, Bernd Kreikemeyer, Brigitte Müller-Hilke

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. A novel small molecule KMU-11361 attenuates rheumatoid arthritis by mechanistic inhibition of the TAK1-NF-κB-NLRP3 axis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. The Periodontopathic Pathogen,Pathogens (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Infection WithFrontiers in immunology · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Paul M LübckeInstitute for Immunology, University Medical Center Rostock, Rostock, Germany.
Meinolf N B EbbersInstitute for Immunology, University Medical Center Rostock, Rostock, Germany.
Johann VolzkeInstitute for Immunology, University Medical Center Rostock, Rostock, Germany.ORCID http://orcid.org/0000-0002-7509-6276
Jana BullInstitute of Medical Microbiology, Virology and Hygiene, University Medical Center Rostock, Rostock, Germany.
Susanne KneitzPhysiological Chemistry, Theodor Boveri Institute (Biocenter), University of Wuerzburg, Wuerzburg, Germany.
Robby EngelmannInstitute for Immunology, University Medical Center Rostock, Rostock, Germany.
Hermann LangDepartment of Operative Dentistry and Periodontology, University Medical Center Rostock, Rostock, Germany.
Bernd KreikemeyerInstitute of Medical Microbiology, Virology and Hygiene, University Medical Center Rostock, Rostock, Germany.
Brigitte Müller-HilkeInstitute for Immunology, University Medical Center Rostock, Rostock, Germany. brigitte.mueller-hilke@med.uni-rostock.de.
University of Rostock · DEUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies indicate a causal relationship between the periodontal pathogen P. gingivalis and rheumatoid arthritis involving the production of autoantibodies against citrullinated peptides. We therefore postulated that therapeutic eradication P. gingivalis may ameliorate rheumatoid arthritis development and here turned to a mouse model in order to challenge our hypothesis. F1 (DBA/1 x B10.Q) mice were orally inoculated with P. gingivalis before collagen-induced arthritis was provoked. Chlorhexidine or metronidazole were orally administered either before or during the induction phase of arthritis and their effects on arthritis progression and alveolar bone loss were compared to intraperitoneally injected methotrexate. Arthritis incidence and severity were macroscopically scored and alveolar bone loss was evaluated via microcomputed tomography. Serum antibody titres against P. gingivalis were quantified by ELISA and microbial dysbiosis following oral inoculation was monitored in stool samples via microbiome analyses. Both, oral chlorhexidine and metronidazole reduced the incidence and ameliorated the severity of collagen-induced arthritis comparable to methotrexate. Likewise, all three therapies attenuated alveolar bone loss. Relative abundance of Porphyromonadaceae was increased after oral inoculation with P. gingivalis and decreased after treatment. This is the first study to describe beneficial effects of non-surgical periodontal treatment on collagen-induced arthritis in mice and suggests that mouthwash with chlorhexidine or metronidazole may also be beneficial for patients with rheumatoid arthritis and a coexisting periodontitis. Methotrexate ameliorated periodontitis in mice, further raising the possibility that methotrexate may also positively impact on the tooth supporting tissues of patients with rheumatoid arthritis.

Indexed as

Alveolar Bone LossAnimalsArthritis, ExperimentalArthritis, RheumatoidAutoantibodiesChlorhexidineCollagenDisease ProgressionInjections, IntraperitonealMaleMethotrexateMetronidazoleMiceMice, Inbred DBAPeriodontitisPorphyromonas gingivalisAutoantibodiesChlorhexidineCollagenMethotrexateMetronidazole

Identifiers

PMID31148565
PMCPMC6544621
OpenAlexW2947788470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.